speb/financial-data huggingface dataset:
CHRS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CHRS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 6700000.00
CHRS income_statement (quarterly, 2025-06-30) — Pretax Income: -44862000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CHRS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -20726000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Receivables: 119639000.00
CHRS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 3395000.00
CHRS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1016000.00
CHRS income_statement (quarterly, 2025-06-30) — Research And Development: 26306000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1309795000.00
CHRS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
CHRS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 26039000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Share Issued: 116222726.00
CHRS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CHRS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5421000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 119827000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 67515000.00
CHRS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CHRS income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
CHRS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CHRS balance_sheet (quarterly, 2025-06-30) — Total Assets: 439464000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 156694000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Total Debt: 41029000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 119827000.00
CHRS income_statement (quarterly, 2025-06-30) — Total Expenses: 55740000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 319637000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 59259000.00
CHRS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 54518000.00
CHRS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -45486000.00
CHRS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CHRS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CHRS balance_sheet (quarterly, 2025-06-30) — Working Capital: 115086000.00
CHRS income_statement (quarterly, 2025-09-30) — +Operating Expense: 52183000.00
CHRS income_statement (quarterly, 2025-09-30) — +Total Revenue: 11571000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 24893000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 9245000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -19336000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1433291000.00
CHRS cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 1646000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
CHRS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 116229170.00
CHRS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.31
CHRS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 217156000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3737000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 12000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 103352000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 191663000.00
CHRS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2000.00
CHRS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -67227000.00
CHRS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -46339000.00
CHRS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -15301000.00
CHRS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -17416000.00
CHRS cash_flow (quarterly, 2025-09-30) — Change In Inventory: 2480000.00
CHRS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 23188000.00
CHRS cash_flow (quarterly, 2025-09-30) — Change In Payable: -15301000.00
CHRS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -32717000.00
CHRS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1926000.00
CHRS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -4266000.00
CHRS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -9389000.00
CHRS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -4266000.00
CHRS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -113564000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Common Stock: 12000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 87774000.00
CHRS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CHRS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 3721000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 78320000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Current Assets: 460955000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1791000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1791000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 373787000.00
CHRS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 966000.00
CHRS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 966000.00
CHRS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 116229170.00
CHRS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.31
CHRS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -35531000.00
CHRS income_statement (quarterly, 2025-09-30) — EBIT: -42192000.00
CHRS income_statement (quarterly, 2025-09-30) — EBITDA: -41226000.00
CHRS cash_flow (quarterly, 2025-09-30) — End Cash Position: 103592000.00
CHRS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Finished Goods: 2048000.00
CHRS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -46339000.00
CHRS cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
CHRS cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: 422000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -203000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 49484000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 20969000.00
CHRS income_statement (quarterly, 2025-09-30) — Gross Profit: 7850000.00
CHRS income_statement (quarterly, 2025-09-30) — Interest Expense: 2325000.00
CHRS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 2325000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Inventory: 2048000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 124731000.00
CHRS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -67227000.00
CHRS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CHRS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CHRS balance_sheet (quarterly, 2025-09-30) — Leases: 5751000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1946000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 36957000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 38903000.00
CHRS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CHRS cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
CHRS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 15218000.00
CHRS cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CHRS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CHRS income_statement (quarterly, 2025-09-30) — Net Income: -35531000.00
CHRS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -35531000.00
CHRS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -44517000.00
CHRS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 8986000.00
CHRS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -35531000.00
CHRS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -44517000.00
CHRS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -35531000.00
CHRS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -35531000.00
CHRS income_statement (quarterly, 2025-09-30) — Net Interest Income: -2325000.00
CHRS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -67200000.00
CHRS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
CHRS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
CHRS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -2325000.00
CHRS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 2000.00
CHRS cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -27000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Net PPE: 1633000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 38290000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1102000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1102000.00
CHRS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -41226000.00
CHRS income_statement (quarterly, 2025-09-30) — Normalized Income: -44517000.00
CHRS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -46339000.00
CHRS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 422000.00
CHRS income_statement (quarterly, 2025-09-30) — Operating Income: -44333000.00
CHRS income_statement (quarterly, 2025-09-30) — Operating Revenue: 11571000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 116236018.00
CHRS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 8700000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1490000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -203000.00
CHRS income_statement (quarterly, 2025-09-30) — Other Income Expense: 2141000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 49484000.00
CHRS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -7842000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 4447000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 14953000.00
CHRS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 2141000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Other Payable: 253908000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 241251000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 88311000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Payables: 278801000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 357121000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 13385000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CHRS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 8048000.00
CHRS income_statement (quarterly, 2025-09-30) — Pretax Income: -44517000.00
CHRS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
CHRS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CHRS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -68850000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Receivables: 250496000.00
CHRS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 3721000.00
CHRS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 966000.00
CHRS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
CHRS income_statement (quarterly, 2025-09-30) — Research And Development: 27252000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1345326000.00
CHRS cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
CHRS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 1650000.00
CHRS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 24931000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Share Issued: 116236018.00
CHRS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CHRS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3389000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 87774000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 38290000.00
CHRS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CHRS income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
CHRS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CHRS balance_sheet (quarterly, 2025-09-30) — Total Assets: 516519000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 124731000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Total Debt: 40694000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 87774000.00
CHRS income_statement (quarterly, 2025-09-30) — Total Expenses: 55904000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 428745000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 55564000.00
CHRS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 54958000.00
CHRS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -44333000.00
CHRS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
CHRS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CHRS balance_sheet (quarterly, 2025-09-30) — Working Capital: 87168000.00
CHRS income_statement (annual, 2025-12-31) — +Operating Expense: 209492000.00
CHRS income_statement (quarterly, 2025-12-31) — +Operating Expense: 54583000.00
CHRS income_statement (annual, 2025-12-31) — +Total Revenue: 42172000.00
CHRS income_statement (quarterly, 2025-12-31) — +Total Revenue: 12748000.00
CHRS balance_sheet (annual, 2025-12-31) — Accounts Payable: 9915000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 9915000.00
CHRS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 17815000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 17815000.00
CHRS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -15233000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -15233000.00
CHRS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1444166000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1444166000.00
CHRS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 4164000.00
CHRS cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 2518000.00
CHRS balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
CHRS balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
CHRS income_statement (annual, 2025-12-31) — Basic Average Shares: 117143457.00
CHRS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 120369638.00
CHRS income_statement (annual, 2025-12-31) — Basic EPS: 1.43
CHRS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.31
CHRS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 126250000.00
CHRS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 103592000.00
CHRS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 3285000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 3285000.00
CHRS balance_sheet (annual, 2025-12-31) — Capital Stock: 12000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 12000.00
CHRS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 88879000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 88879000.00
CHRS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 172125000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 172125000.00
CHRS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -273705000.00
CHRS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 8081000.00
CHRS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 375087000.00
CHRS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2838000.00
CHRS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -138513000.00
CHRS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -19716000.00
CHRS cash_flow (annual, 2025-12-31) — Change In Account Payable: -19556000.00
CHRS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -5088000.00
CHRS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -132291000.00
CHRS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -24582000.00
CHRS cash_flow (annual, 2025-12-31) — Change In Inventory: -17108000.00
CHRS cash_flow (quarterly, 2025-12-31) — Change In Inventory: -1114000.00
CHRS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 64446000.00
CHRS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 51805000.00
CHRS cash_flow (annual, 2025-12-31) — Change In Payable: -19556000.00
CHRS cash_flow (quarterly, 2025-12-31) — Change In Payable: -5088000.00
CHRS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -151847000.00
CHRS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -29670000.00
CHRS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 5110000.00
CHRS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 3657000.00
CHRS cash_flow (annual, 2025-12-31) — Change In Receivables: 93557000.00
CHRS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -8338000.00
CHRS cash_flow (annual, 2025-12-31) — Change In Working Capital: -5842000.00
CHRS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 16340000.00
CHRS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 93557000.00
CHRS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -8338000.00
CHRS cash_flow (annual, 2025-12-31) — Changes In Cash: -37131000.00
CHRS cash_flow (quarterly, 2025-12-31) — Changes In Cash: -14473000.00
CHRS balance_sheet (annual, 2025-12-31) — Common Stock: 12000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Common Stock: 12000.00
CHRS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 61014000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 61014000.00
CHRS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 7894000.00
CHRS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 7894000.00
CHRS income_statement (annual, 2025-12-31) — Cost Of Revenue: 13814000.00
CHRS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4045000.00
CHRS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 114064000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 114064000.00
CHRS balance_sheet (annual, 2025-12-31) — Current Assets: 206706000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Current Assets: 206706000.00
CHRS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1828000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1828000.00
CHRS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1828000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1828000.00
CHRS balance_sheet (annual, 2025-12-31) — Current Liabilities: 141876000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 141876000.00
CHRS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3924000.00
CHRS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 896000.00
CHRS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3924000.00
CHRS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 896000.00
CHRS income_statement (annual, 2025-12-31) — Diluted Average Shares: 117143457.00
CHRS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 120369638.00
CHRS income_statement (annual, 2025-12-31) — Diluted EPS: 1.43
CHRS income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.31
CHRS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 168024000.00
CHRS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -37643000.00
CHRS income_statement (annual, 2025-12-31) — EBIT: -174123000.00
CHRS income_statement (quarterly, 2025-12-31) — EBIT: -44098000.00
CHRS income_statement (annual, 2025-12-31) — EBITDA: -170199000.00
CHRS income_statement (quarterly, 2025-12-31) — EBITDA: -43202000.00
CHRS cash_flow (annual, 2025-12-31) — End Cash Position: 89119000.00
CHRS cash_flow (quarterly, 2025-12-31) — End Cash Position: 89119000.00
CHRS cash_flow (annual, 2025-12-31) — Financing Cash Flow: -273705000.00
CHRS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 8081000.00
CHRS cash_flow (annual, 2025-12-31) — Free Cash Flow: -138513000.00
CHRS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -19716000.00
CHRS cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 12608000.00
CHRS cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
CHRS cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -338315000.00
CHRS cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 365000.00
CHRS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -195000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -195000.00
CHRS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 46239000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 46239000.00
CHRS balance_sheet (annual, 2025-12-31) — Gross PPE: 16578000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 16578000.00
CHRS income_statement (annual, 2025-12-31) — Gross Profit: 28358000.00
CHRS income_statement (quarterly, 2025-12-31) — Gross Profit: 8703000.00
CHRS cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 36000.00
CHRS income_statement (annual, 2025-12-31) — Interest Expense: 9001000.00
CHRS income_statement (quarterly, 2025-12-31) — Interest Expense: 2249000.00
CHRS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 9001000.00
CHRS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2249000.00
CHRS cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 9916000.00
CHRS balance_sheet (annual, 2025-12-31) — Inventory: 3172000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Inventory: 3172000.00
CHRS balance_sheet (annual, 2025-12-31) — Invested Capital: 98065000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 98065000.00
CHRS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 375087000.00
CHRS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2838000.00
CHRS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 7894000.00
CHRS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 7894000.00
CHRS balance_sheet (annual, 2025-12-31) — Leases: 5763000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Leases: 5763000.00
CHRS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1457000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1457000.00
CHRS balance_sheet (annual, 2025-12-31) — Long Term Debt: 37051000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 37051000.00
CHRS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 38508000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 38508000.00
CHRS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -280837000.00
CHRS cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -47652000.00
CHRS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 10815000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 10815000.00
CHRS cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 457805000.00
CHRS cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -20876000.00
CHRS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 7894000.00
CHRS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 7894000.00
CHRS income_statement (annual, 2025-12-31) — Net Income: 168024000.00
CHRS income_statement (quarterly, 2025-12-31) — Net Income: -37643000.00
CHRS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 168024000.00
CHRS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -37643000.00
CHRS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -183124000.00
CHRS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -46347000.00
CHRS income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 351148000.00
CHRS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 8704000.00
CHRS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 168024000.00
CHRS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -37643000.00
CHRS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -183124000.00
CHRS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -46347000.00
CHRS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 168024000.00
CHRS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -37643000.00
CHRS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 168024000.00
CHRS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -37643000.00
CHRS income_statement (annual, 2025-12-31) — Net Interest Income: -9001000.00
CHRS income_statement (quarterly, 2025-12-31) — Net Interest Income: -2249000.00
CHRS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -82376000.00
CHRS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 5550000.00
CHRS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -280837000.00
CHRS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -47652000.00
CHRS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -280837000.00
CHRS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -47652000.00
CHRS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -9001000.00
CHRS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2249000.00
CHRS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1115000.00
CHRS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 47674000.00
CHRS cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -342000.00
CHRS cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 12488000.00
CHRS balance_sheet (annual, 2025-12-31) — Net PPE: 1345000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Net PPE: 1345000.00
CHRS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 14775000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 14775000.00
CHRS balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1102000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1102000.00
CHRS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1102000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1102000.00
CHRS income_statement (annual, 2025-12-31) — Normalized EBITDA: -170199000.00
CHRS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -43202000.00
CHRS income_statement (annual, 2025-12-31) — Normalized Income: -183124000.00
CHRS income_statement (quarterly, 2025-12-31) — Normalized Income: -46347000.00
CHRS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -138513000.00
CHRS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -19716000.00
CHRS cash_flow (annual, 2025-12-31) — Operating Gains Losses: -315421000.00
CHRS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 365000.00
CHRS income_statement (annual, 2025-12-31) — Operating Income: -181134000.00
CHRS income_statement (quarterly, 2025-12-31) — Operating Income: -45880000.00
CHRS income_statement (annual, 2025-12-31) — Operating Revenue: 42172000.00
CHRS income_statement (quarterly, 2025-12-31) — Operating Revenue: 12748000.00
CHRS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 121154925.00
CHRS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 121154925.00
CHRS balance_sheet (annual, 2025-12-31) — Other Current Assets: 6233000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 6233000.00
CHRS balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1490000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1490000.00
CHRS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -195000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -195000.00
CHRS income_statement (annual, 2025-12-31) — Other Income Expense: 7011000.00
CHRS income_statement (quarterly, 2025-12-31) — Other Income Expense: 1782000.00
CHRS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 46239000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 46239000.00
CHRS cash_flow (annual, 2025-12-31) — Other Non Cash Items: -10328000.00
CHRS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -4976000.00
CHRS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 4053000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 4053000.00
CHRS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 15843000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 15843000.00
CHRS income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 7011000.00
CHRS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1782000.00
CHRS balance_sheet (annual, 2025-12-31) — Other Receivables: 603000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 603000.00
CHRS balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 83246000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 83246000.00
CHRS balance_sheet (annual, 2025-12-31) — Payables: 9915000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Payables: 9915000.00
CHRS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 123979000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 123979000.00
CHRS balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 14579000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 14579000.00
CHRS balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CHRS balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CHRS balance_sheet (annual, 2025-12-31) — Prepaid Assets: 6758000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 6758000.00
CHRS income_statement (annual, 2025-12-31) — Pretax Income: -183124000.00
CHRS income_statement (quarterly, 2025-12-31) — Pretax Income: -46347000.00
CHRS cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 353000.00
CHRS cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 165000.00
CHRS balance_sheet (annual, 2025-12-31) — Properties: 0.00
CHRS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CHRS cash_flow (annual, 2025-12-31) — Purchase Of Business: -12500000.00
CHRS cash_flow (annual, 2025-12-31) — Purchase Of Investment: -103838000.00
CHRS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -14262000.00
CHRS balance_sheet (annual, 2025-12-31) — Receivables: 18418000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Receivables: 18418000.00
CHRS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 13814000.00
CHRS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4045000.00
CHRS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3924000.00
CHRS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 896000.00
CHRS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -280837000.00
CHRS cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -47652000.00
CHRS income_statement (annual, 2025-12-31) — Research And Development: 108888000.00
CHRS income_statement (quarterly, 2025-12-31) — Research And Development: 30974000.00
CHRS balance_sheet (annual, 2025-12-31) — Retained Earnings: -1382969000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1382969000.00
CHRS cash_flow (annual, 2025-12-31) — Sale Of Business: 470305000.00
CHRS cash_flow (quarterly, 2025-12-31) — Sale Of Business: -8376000.00
CHRS cash_flow (annual, 2025-12-31) — Sale Of Investment: 21462000.00
CHRS cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 19812000.00
CHRS income_statement (annual, 2025-12-31) — Selling General And Administration: 100604000.00
CHRS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 23609000.00
CHRS balance_sheet (annual, 2025-12-31) — Share Issued: 121154925.00
CHRS balance_sheet (quarterly, 2025-12-31) — Share Issued: 121154925.00
CHRS income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CHRS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CHRS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 16966000.00
CHRS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2784000.00
CHRS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 61014000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 61014000.00
CHRS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 14775000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 14775000.00
CHRS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CHRS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CHRS income_statement (annual, 2025-12-31) — Tax Provision: 0.00
CHRS income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
CHRS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CHRS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CHRS balance_sheet (annual, 2025-12-31) — Total Assets: 258343000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Total Assets: 258343000.00
CHRS balance_sheet (annual, 2025-12-31) — Total Capitalization: 98065000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 98065000.00
CHRS balance_sheet (annual, 2025-12-31) — Total Debt: 40336000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Total Debt: 40336000.00
CHRS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 61014000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 61014000.00
CHRS income_statement (annual, 2025-12-31) — Total Expenses: 223306000.00
CHRS income_statement (quarterly, 2025-12-31) — Total Expenses: 58628000.00
CHRS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 197329000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 197329000.00
CHRS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 51637000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 51637000.00
CHRS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 55453000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 55453000.00
CHRS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -181134000.00
CHRS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -45880000.00
CHRS income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
CHRS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
CHRS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CHRS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CHRS balance_sheet (annual, 2025-12-31) — Working Capital: 64830000.00
CHRS balance_sheet (quarterly, 2025-12-31) — Working Capital: 64830000.00
CHRS income_statement (quarterly, 2026-03-31) — +Operating Expense: 44647000.00
CHRS income_statement (quarterly, 2026-03-31) — +Total Revenue: 12310000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 11479000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 22064000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1500172000.00
CHRS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 136398303.00
CHRS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.28
CHRS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 89119000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2853000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 15000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 115238000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 167048000.00
CHRS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 53590000.00
CHRS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 30655000.00
CHRS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -57886000.00
CHRS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 2564000.00
CHRS cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -8762000.00
CHRS cash_flow (quarterly, 2026-03-31) — Change In Inventory: -11312000.00
CHRS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -3303000.00
CHRS cash_flow (quarterly, 2026-03-31) — Change In Payable: 2564000.00
CHRS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -6198000.00
CHRS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 1414000.00
CHRS cash_flow (quarterly, 2026-03-31) — Change In Receivables: -4282000.00
CHRS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -23681000.00
CHRS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -4282000.00
CHRS cash_flow (quarterly, 2026-03-31) — Changes In Cash: 26359000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Common Stock: 15000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 78623000.00
CHRS cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 53650000.00
CHRS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3814000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 103674000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Current Assets: 206035000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1899000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1899000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 133822000.00
CHRS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 881000.00
CHRS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 881000.00
CHRS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 136398303.00
CHRS income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.28
CHRS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -38327000.00
CHRS income_statement (quarterly, 2026-03-31) — EBIT: -34749000.00
CHRS income_statement (quarterly, 2026-03-31) — EBITDA: -33868000.00
CHRS cash_flow (quarterly, 2026-03-31) — End Cash Position: 115478000.00
CHRS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 53590000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 4825000.00
CHRS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -57886000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -268000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 45614000.00
CHRS income_statement (quarterly, 2026-03-31) — Gross Profit: 8496000.00
CHRS income_statement (quarterly, 2026-03-31) — Interest Expense: 2186000.00
CHRS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2186000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Inventory: 4825000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 115770000.00
CHRS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 30655000.00
CHRS cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 53650000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 954000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 37147000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 38101000.00
CHRS cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 53650000.00
CHRS income_statement (quarterly, 2026-03-31) — Net Income: -38327000.00
CHRS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -38327000.00
CHRS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -36935000.00
CHRS income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: -1392000.00
CHRS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -38327000.00
CHRS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -36935000.00
CHRS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -38327000.00
CHRS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -38327000.00
CHRS income_statement (quarterly, 2026-03-31) — Net Interest Income: -2186000.00
CHRS cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 31747000.00
CHRS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2186000.00
CHRS cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -60000.00
CHRS cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -1092000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Net PPE: 1094000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 33009000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1102000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1102000.00
CHRS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -33868000.00
CHRS income_statement (quarterly, 2026-03-31) — Normalized Income: -36935000.00
CHRS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -57886000.00
CHRS income_statement (quarterly, 2026-03-31) — Operating Income: -36151000.00
CHRS income_statement (quarterly, 2026-03-31) — Operating Revenue: 11803000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 154217609.00
CHRS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 9379000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1490000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -268000.00
CHRS income_statement (quarterly, 2026-03-31) — Other Income Expense: 1402000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 45614000.00
CHRS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 856000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 13279000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 14374000.00
CHRS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1402000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 446000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 51810000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Payables: 11479000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 115153000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15280000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CHRS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 2273000.00
CHRS income_statement (quarterly, 2026-03-31) — Pretax Income: -36935000.00
CHRS cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -6388000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Receivables: 22510000.00
CHRS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3814000.00
CHRS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 881000.00
CHRS income_statement (quarterly, 2026-03-31) — Research And Development: 21543000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1421296000.00
CHRS cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 38135000.00
CHRS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 23104000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Share Issued: 154217609.00
CHRS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2385000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 78623000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 33009000.00
CHRS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CHRS income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
CHRS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CHRS balance_sheet (quarterly, 2026-03-31) — Total Assets: 266022000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 115770000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Total Debt: 40000000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 78623000.00
CHRS income_statement (quarterly, 2026-03-31) — Total Expenses: 48461000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 187399000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 59987000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 53577000.00
CHRS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -36151000.00
CHRS balance_sheet (quarterly, 2026-03-31) — Working Capital: 72213000.00
CHRT.L income_statement (annual, 2022-04-30) — +Operating Expense: 47945000.00
CHRT.L income_statement (annual, 2022-04-30) — +Total Revenue: 137765000.00
CHRT.L balance_sheet (annual, 2022-04-30) — Accounts Payable: 9648000.00
CHRT.L balance_sheet (annual, 2022-04-30) — Accounts Receivable: 24410000.00
CHRT.L balance_sheet (annual, 2022-04-30) — Accumulated Depreciation: -16905000.00
CHRT.L balance_sheet (annual, 2022-04-30) — Additional Paid In Capital: 30527000.00
CHRT.L balance_sheet (annual, 2022-04-30) — Allowance For Doubtful Accounts Receivable: -657000.00
CHRT.L income_statement (annual, 2022-04-30) — Amortization: 6865000.00
CHRT.L cash_flow (annual, 2022-04-30) — Amortization Cash Flow: 6865000.00
CHRT.L income_statement (annual, 2022-04-30) — Basic Average Shares: 40813569.00
CHRT.L income_statement (annual, 2022-04-30) — Basic EPS: 0.23